Advertisement

Biotechnology company MDRNA Inc. said Tuesday it bought DNA technology-related patents from Valeant Pharmaceuticals for an undisclosed amount.

The patents give MDRNA considerable breadth in the research and development of nucleic acid-based therapies, MDRNA said, in a statement.

MDRNA is developing drugs that fight cancer and other diseases with "gene-silencing" RNA interference technology.

Advertisement
Advertisement